Water for injection market to hit $47.63B by 2030

The global water for injection market is forecast to grow from $30.45 billion in 2025 to $47.63 billion by 2030, driven by demand from pharmaceuticals, healthcare infrastructure spending and rising biologics production. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Water for injection is a core input for injectable and parenteral drugs, so market growth tracks demand in pharmaceuticals, healthcare and biologics. - Rising diabetes cases are adding to demand for sterile water used to reconstitute or dilute injectable medicines such as insulin. - The market outlook points to continued investment in purification, sterile processing and pharmaceutical manufacturing capacity.

What happened: - The Business Research Company said the water for injection market was valued at $30.45 billion in 2025 and is projected to reach $33.38 billion in 2026. - The market is forecast to grow to $47.63 billion by 2030, implying a 9.3% compound annual growth rate from 2026 to 2030. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region over the forecast period. - The report covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The company published a free sample report at the sample report and the full report at the full market report.

The details: - Water for injection is sterile, highly purified water used to prepare injectable drugs. - The product must be free of contaminants, including pyrogens, to meet intravenous use requirements. - Common production methods include distillation and reverse osmosis. - The report links earlier growth to limited purified water production technologies, growth in injectable formulations, hospital infrastructure expansion, strict pharmacopeial rules and dependence on concentrated manufacturing hubs. - The forecast period is supported by advances in distillation and membrane-based purification, higher pharmaceutical manufacturing investment, growth in biologics and vaccine production, expansion of CROs and CMOs, and adoption of automation and smart manufacturing. - Emerging trends include stronger demand for ultra-pure water in injectable drugs, broader use of advanced sterilization and filtration, tighter compliance requirements, more pharmaceutical and biotechnology manufacturing, and wider use in research and laboratory settings. - The report says the market is being fueled in part by global diabetes growth. - In February 2025, the Health Professional Academy reported UK diabetes diagnoses reached a record 4.6 million, up from 4.4 million the year before.

Between the lines: - The market is expanding because water for injection sits at the intersection of drug safety, manufacturing scale and regulation. - Regional leadership suggests mature pharmaceutical ecosystems still dominate today, while newer manufacturing investment is shifting growth toward Asia-Pacific. - The report’s emphasis on automation and smart manufacturing suggests buyers are looking for efficiency as well as compliance.

What's next: - Demand is likely to rise as injectable, biologic and vaccine production expands. - Manufacturers are expected to invest more in purification systems, filtration and sterile processing capacity. - The report highlights growing use in research and laboratory settings as an additional demand driver. - The Business Research Company also said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics and updated graphics and tables.